Page last updated: 2024-11-05

tripropylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tripropylammonium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tripropylamine : A tertiary amine that is ammonia in which each hydrogen atom is substituted by a propyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7616
CHEBI ID38880
SCHEMBL ID5358
MeSH IDM0253205

Synonyms (43)

Synonym
NCIOPEN2_001723
einecs 203-047-7
tripropylamine [un2260] [flammable liquid]
hsdb 2097
tripropylammonium
un2260
tri-n-propylamine
1-propanamine, n,n-dipropyl-
inchi=1/c9h21n/c1-4-7-10(8-5-2)9-6-3/h4-9h2,1-3h
102-69-2
n,n-dipropylpropan-1-amine
tripropylamine
tripropylamine, >=98%
n,n-dipropyl-1-propanamine
npr3
propyldi-n-propylamine
CHEBI:38880
(n-c3h7)3n
FT-0656542
T0522
AKOS000120960
tripropylamine [un2260] [flammable liquid]
ec 203-047-7
06s624v3u2 ,
unii-06s624v3u2
tripropylamine [fhfi]
tripropylamine [hsdb]
fema no. 4247
tri-n-propyl-amine
tri-n-propyl amin
tri(n-propyl)amine
tripropyl amine
SCHEMBL5358
n,n-dipropyl-1-propylamine
un 2260
DTXSID9021849
J-000767
J-523283
n,n-dpropyl-1-propanamne
mfcd00009363
tripropylamine, analytical standard
Q1637944
tris(1-propyl)amine

Research Excerpts

Overview

Tripropylamine (TPA) is a template for the synthesis of porous AlPO(4)-5. calcination in the absence of air leads to the formation of 4 A single-walled carbon nanotubes.

ExcerptReferenceRelevance
"Tripropylamine (TPA) is a template for the synthesis of porous AlPO(4)-5, whose calcination in the absence of air leads to the formation of 4 A single-walled carbon nanotubes. "( Thermal dissociation of tripropylamine as the first step in the growth of carbon nanotubes inside AlPO4-5 channels.
Liu, JW; Liu, ZF, 2010
)
2.11

Effects

ExcerptReferenceRelevance
"Tripropylamine (TPA) has different oxidation efficiency at double stranded (ds)-and single stranded (ss)-DNA-modified electrodes. "( Electrochemical aptasensor using the tripropylamine oxidation to probe intramolecular displacement between target and complementary nucleotide for protein array.
He, XW; Liu, DY; Yin, XB; Zhao, Y, 2011
)
2.08
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tertiary amineA compound formally derived from ammonia by replacing three hydrogen atoms by hydrocarbyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.64)18.7374
1990's1 (1.64)18.2507
2000's24 (39.34)29.6817
2010's30 (49.18)24.3611
2020's5 (8.20)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.23

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.23 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index5.73 (4.65)
Search Engine Demand Index60.87 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.23)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]